Clinical trial
AnalyST & Brugada Syndrome - Feasibility Study
NCT02052765 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AnalyST & Brugada Syndrome - Feasibility Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- May 31, 2011
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.